Clinical Trial Update: Safety and Efficacy of CJ-50300 in Healthy Volunteers [Phase 2, Phase 3]

View source ↗

Summary

This report summarizes the results of a Phase 2/3 trial evaluating CJ-50300 for safety and efficacy in healthy volunteers in the context of smallpox; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox

Drugs mentioned

• CJ-50300

Snippet

Sponsor: Seoul National University Hospital | Conditions: Smallpox | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-07-09